/4880.T
4880.T Stock - CellSource Co., Ltd.
Healthcare|BiotechnologyJPX
$392.00-2.97%
$12.00 (-2.97%) • Dec 24
55
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.1
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $431.20
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for 4880.T
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$388.08 – $395.92
TARGET (TP)$450.80
STOP LOSS$360.64
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-0.21
52W High$885.00
52W Low$386.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $3.71B | $4.36B | $4.51B | $4.27B | $2.92B |
| Gross Profit | $2.09B | $2.42B | $3.18B | $3.06B | $2.07B |
| Gross Margin | 56.2% | 55.5% | 70.6% | 71.7% | 71.0% |
| Operating Income | $166.71M | $129.16M | $1.22B | $1.57B | $992.44M |
| Net Income | $10.66M | $237.94M | $923.14M | $1.02B | $651.40M |
| Net Margin | 0.3% | 5.5% | 20.5% | 23.8% | 22.3% |
| EPS | $0.54 | $12.01 | $48.88 | $54.54 | $35.17 |
Company Overview
CellSource Co., Ltd. engages in the regenerative medicine-related and consumer businesses. It also offers Signalift, an anti-aging product. The company was incorporated in 2015 and is headquartered in Tokyo, Japan.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
4880.TBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$3.78
Q3 2025
EPS Surprise History
Q4 23
No data
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Q3 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Dec 11, 2025 | — | — | — | — |
Q3 2025 | Sep 11, 2025 | — | $3.78 | — | — |
Q2 2025 | Jun 12, 2025 | — | $2.86 | — | — |
Q1 2025 | Mar 11, 2025 | — | $-2.29 | — | — |
Q4 2024 | Dec 13, 2024 | — | $-6.88 | — | — |
Q3 2024 | Sep 12, 2024 | — | $3.73 | — | — |
Q2 2024 | Jun 13, 2024 | — | $7.84 | — | — |
Q1 2024 | Mar 11, 2024 | — | $7.23 | — | — |
Q4 2023 | Dec 15, 2023 | — | $12.78 | — | — |
Q3 2023 | Sep 13, 2023 | — | $13.80 | — | — |
Q2 2023 | Jun 14, 2023 | — | $10.10 | — | — |
Q1 2023 | Mar 14, 2023 | — | $11.24 | — | — |
Q4 2022 | Dec 14, 2022 | — | $22.31 | — | — |
Q3 2022 | Sep 13, 2022 | — | $14.62 | — | — |
Q2 2022 | Jun 13, 2022 | — | $7.95 | — | — |
Q1 2022 | Mar 16, 2022 | — | $8.11 | — | — |
Q4 2021 | Dec 13, 2021 | — | $12.10 | — | — |
Q3 2021 | Sep 10, 2021 | — | $8.64 | — | — |
Q2 2021 | Jun 14, 2021 | — | $8.44 | — | — |
Q1 2021 | Mar 15, 2021 | — | $5.89 | — | — |
Latest News
Loading news...
Frequently Asked Questions about 4880.T
What is 4880.T's current stock price?
CellSource Co., Ltd. (4880.T) is currently trading at $392.00 per share. The stock has moved -2.97% today.
What is the analyst price target for 4880.T?
No analyst price targets are currently available for this stock.
What sector is CellSource Co., Ltd. in?
CellSource Co., Ltd. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the JPX exchange.
What is 4880.T's market cap?
CellSource Co., Ltd. has a market capitalization of $7.77 billion, making it a mid-cap company.
Does 4880.T pay dividends?
No, CellSource Co., Ltd. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare Sector177A.T
Kohjin Bio Co., Ltd.
$1477.00
Mkt Cap: $7.5B
2183.T
Linical Co., Ltd.
$293.00
Mkt Cap: $6.6B
2370.T
MEDINET Co., Ltd.
$27.00
Mkt Cap: $7.1B
4571.T
NANO MRNA Co.,Ltd.
$134.00
Mkt Cap: $9.5B
4583.T
Chiome Bioscience Inc.
$109.00
Mkt Cap: $7.4B
4584.T
Kidswell Bio Corporation
$199.00
Mkt Cap: $9.9B
4875.T
MediciNova, Inc.
$212.00
Mkt Cap: $10.4B
4888.T
Stella Pharma Corporation
$208.00
Mkt Cap: $7.1B
7096.T
StemCell Institute Inc.
$771.00
Mkt Cap: $7.9B
9341.T
GENOVA, Inc.
$566.00
Mkt Cap: $9.8B
Explore stocks similar to 4880.T for comparison